Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ubiquitin Specific Protease 29 Functions as an Oncogene Promoting Tumorigenesis in Colorectal Carcinoma
Arun Pandian Chandrasekaran, Bharathi Suresh, Neha Sarodaya, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2706-2706
Open Access | Times Cited: 20

Showing 20 citing articles:

Deubiquitinase Ubiquitin‐Specific Protease 29 Ameliorates Pathological Cardiac Hypertrophy through Inhibiting Transforming Growth Factor β‐Activated Kinase 1
Xi Jiang, Yan Sun, Hongjie Shi, et al.
Journal of the American Heart Association (2025)
Open Access | Times Cited: 1
Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
Hui Meng, Manman Nan, Yizhen Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 16
The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b
Wenying Gao, Liuli Wang, Xiaohui Ju, et al.
mBio (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 25
Ethyl cinnamate suppresses tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in colorectal cancer
Siyu Wang, Jianzhan Yang, Xiaolan Kuang, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117913-117913
Closed Access | Times Cited: 5
Engineering CRISPR/Cas9 therapeutics for cancer precision medicine
Aditya Sharma, Anil K Giri
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 5
Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis
Jiaqi Liu, Chi Tim LEUNG, Luyun Liang, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3547-3547
Open Access | Times Cited: 19
Deubiquitinases as novel therapeutic targets in colorectal cancer
Noor Al Shukri, Razik Bin Abdul Momin
Asia-Pacific Journal of Oncology (2025)
Open Access
Therapeutic potential of targeting ubiquitin-specific proteases in colorectal cancer
Chern Ein Oon, Padmanabhan Anbazhagan, Chong Teik Tan
Drug Discovery Today (2025), pp. 104356-104356
Closed Access
Dual role of deubiquitinating enzyme USP19 regulates mitotic progression and tumorigenesis by stabilizing survivin
Arun Pandian Chandrasekaran, Apoorvi Tyagi, Naresh Poondla, et al.
Molecular Therapy (2022) Vol. 30, Iss. 11, pp. 3414-3429
Open Access | Times Cited: 18
USP29 activation mediated by FUBP1 promotes AURKB stability and oncogenic functions in gastric cancer
Rongfu Tu, Ye Kang, Yiwen Pan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Emerging roles of deubiquitinating enzymes in actin cytoskeleton and tumor metastasis
Ying Xue, Cong Xue, Wei Song
Cellular Oncology (2024) Vol. 47, Iss. 4, pp. 1071-1089
Closed Access | Times Cited: 3
TYMS-TM4SF4 axis promotes the progression of colorectal cancer by EMT and upregulating stem cell marker.
Fen Zhang, Jiecheng Ye, Wenjing Guo, et al.
PubMed (2022) Vol. 12, Iss. 3, pp. 1009-1026
Closed Access | Times Cited: 13
Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review
Eman Al-Balushi, Amina Al Marzouqi, Shima Tavoosi, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 1, pp. 197-213
Open Access | Times Cited: 2
Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis
Juncai Li, Yang Jianguo, Zhenzhou Chen, et al.
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 10
Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination
Zhongbao Chen, Fengjiao Hu, Yalong Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities
Sunny Kumar, Malini Basu, Mrinal K. Ghosh
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 8, pp. 119827-119827
Closed Access | Times Cited: 1
TRAF4 regulates ubiquitination-modulated survivin turnover and confers radioresistance
Jinzhuang Liao, Qing Xiang, M Kellis, et al.
International Journal of Biological Sciences (2023) Vol. 20, Iss. 1, pp. 182-199
Open Access | Times Cited: 3
Identification of USP29 as a key regulator of nucleotide biosynthesis in neuroblastoma through integrative analysis of multi-omics data
Ye Kang, Yahuan Yu, Yijia Liu, et al.
Cancer Biology & Therapy (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The emerging role of USP29 in cancer and other diseases
Ru Zhang, Zeqiong Cai, Doudou Ren, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access
The Combination of Inositol Hexaphosphate and Inositol Inhibits Metastasis of Colorectal Cancer Cells by Upregulating Claudin 7
Yisa Han, Tongtong Lan, Xuezhen Ma, et al.
Biological and Pharmaceutical Bulletin (2023) Vol. 46, Iss. 8, pp. 1145-1151
Open Access
Page 1

Scroll to top